An FxMed Seminar presented by Dr. Nathan S. Bryan
Learn how to recognize Nitric Oxide deficiency in your patients before the onset and presentation of related disease or symptoms.
Nitric oxide (NO) is one of the most important signaling molecules in our body involved with a host of physiological processes including defense, neuronal communication and the regulation of vascular tone. Loss of NO function is one of the earliest indicators or markers of disease and may manifest early on as sexual dysfunction in both men and women. Clinical studies show that defects of endothelial NO production, is not only associated with all major cardiovascular risk factors such as hyperlipidemia, diabetes, hypertension, erectile dysfunction, smoking and severity of atherosclerosis, but also has a predictive value for future atherosclerotic disease.
This seminar will review clinical studies showing the effects of nitric oxide supplementation on inflammation, sexual function and markers of cardiovascular disease. Dr. Bryan will also discuss how to recognize NO deficiency in patients before the onset and presentation of disease and how NO supplementation may profoundly improve the management of patients through correcting NO homeostasis.
PRESENTER: Dr. Nathan S. Bryan
Dr. Bryan has an undergraduate Bachelor of Science degree in Biochemistry and earned his doctoral degree from Louisiana State University School of Medicine where he was the recipient of the Dean’s Award for Excellence in Research. He pursued his post-doctoral
training at Boston University School of Medicine in the Whitaker Cardiovascular Institute.
In 2006 Dr. Bryan was recruited to join faculty at the University of Texas Health Science Centre in Houston. During his tenure as Faculty and Independent Investigator at UT, his research focused on drug discovery through screening natural product libraries for active compounds. His nine years at UT led to several discoveries which have resulted in seven issued US patents and nine pending worldwide. He is also a successful entrepreneur who has commercialized his nitric oxide technology through the formation of HumanN Inc (formerly Neogenis Medical) where he is Co-founder and Chief Science Officer.
Dr. Bryan has been involved in nitric oxide research for the past 16 years and has made many discoveries in the field. These discoveries and findings have transformed the development of safe and effective functional bioactive natural products in the treatment and prevention of human disease and may provide the basis for new preventive or therapeutic strategies in many chronic diseases. Dr. Bryan has published a number of highly cited papers and authored The Nitric Oxide Solution book. He is an international leader in molecular medicine and natural product chemistry.